Skip to main content
Premium Trial:

Request an Annual Quote

Fluorotechnics '09 Revenues to Fall Short

NEW YORK (GenomeWeb News) – Fluorotechnics, a Sydney, Australia-based supplier of fluorescence and other protein detection technologies, today said that it expects its 2009 revenues to be around A$3.2 million (US$2.5 million), down from its previous forecast of A$4 million.

The firm also cut its 2009-2010 revenue guidance of A$18 million to a range of between A$10 million and A$12 million.

Fluorotechnics said that the shortfall in revenue is due to "unfavorable foreign exchange rate movements." It also noted that product marketing for some of its gel products was delayed until recently, while the firm improved its quality control processes.

"The directors remain confident in the potential market size and selling propositions of our products as well as our competitive position but they recognize that some customer expenditures have been curtailed during the global economic slow down," Fluorotechnics said in a statement.

Earlier this year, Fluorotechnics rebranded itself under the name of a firm it acquired last year, Gelcompany. However, it has continued trade on the Australian Stock Exchange under the Fluorotechnics name and the "FLS" ticker symbol.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.